Wird geladen...
A pharmacological modification of pain and epithelial healing in contemporary transepithelial all-surface laser ablation (ASLA)
PURPOSE: We report our experience with the use of the matrix regenerating agent (RGTA) Cacicol(®) after reverse transepithelial all-surface laser ablation (ASLA)-SCHWIND to assess the safety, efficacy, pain, and epithelial healing. METHODS: Forty eyes of 20 myopic patients were prospectively recruit...
Gespeichert in:
| Veröffentlicht in: | Clin Ophthalmol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4404873/ https://ncbi.nlm.nih.gov/pubmed/25931809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S81061 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|